跳至主要内容
临床试验/ACTRN12605000572662
ACTRN12605000572662尚未招募不适用

The effect of prophylactic preoperative probiotic therapy on perioperative endotoxin levels in cardiac surgery patients.

Intensive Care Unit, RMH0 个研究点目标入组 40 人开始时间: 2005年10月4日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 ot stated(—)
性别
All

入选标准

  • Patients scheduled for elective cardiac surgery requiring cardiopulmonary bypass will be approached for consent to participate in the study.

排除标准

  • Current usage of a probiotic product (eg Yakult, which is freely available as a foodstuff), past history of asthma or recurrent urticaria, pregnancy, HIV infection, immunosupression and pre-existing intestinal disorder. The Lactobacillus acidophilus preparation to be used in this study contains a very small amount of MSG (total dose 20 mg/day, equivalent to 10% of the initial dose used to test for MSG sensitivity) and as a precaution, patients with asthma or recurrent urticaria will be excluded. As the Lactobacillus preparation contains live microrganisms, immunosupressed and pregnant patients will also be excluded.

研究者

发起方
Intensive Care Unit, RMH

相似试验